Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 31, Supplement—April 2025
SUPPLEMENT ISSUE
Supplement

Integrating Genomic Data into Public Health Surveillance for Multidrug-Resistant Organisms, Washington, USA

Laura Marcela Torres1Comments to Author , Jared Johnson1, Audrey Valentine1, Audrey Brezak, Emily C. Schneider, Marisa D’Angeli, Jennifer Morgan, Claire Brostrom-Smith, Chi N. Hua, Michael Tran, Darren Lucas, Joenice Gonzalez De Leon, Drew MacKellar, Philip Dykema, Kelly J. Kauber, and Allison Black
Author affiliation: Washington State Department of Health, Shoreline, Washington, USA (L.M. Torres, J. Johnson, A. Valentine, A. Brezak, E.C. Schneider, M. D’Angeli, C.N. Hua, M. Tran, D. Lucas, J. Gonzalez De Leon, D. Mackellar, P. Dykema, K.J. Kauber, A. Black); Public Health Seattle and King County, Seattle, Washington, USA (J. Morgan, C. Brostrom-Smith)

Main Article

Figure 1

Data flow and cross-team communication channels for our system for integrating genomic data into public health surveillance for multidrug-resistant organisms, Washington, USA. This diagram shows how a sample, then data, move through our integrated surveillance program. Tasks that are handled jointly across programs are highlighted in white. A) Tasks conducted by Washington Public Health Laboratory. B) Tasks conducted by Molecular Epidemiology Program. C) Tasks conducted by Multidrug-Resistant Organism Program and local health jurisdictions.

Figure 1. Data flow and cross-team communication channels for our system for integrating genomic data into public health surveillance for multidrug-resistant organisms, Washington, USA. This diagram shows how a sample, then data, move through our integrated surveillance program. Tasks that are handled jointly across programs are highlighted in white. A) Tasks conducted by Washington Public Health Laboratory. B) Tasks conducted by Molecular Epidemiology Program. C) Tasks conducted by Multidrug-Resistant Organism Program and local health jurisdictions.

Main Article

1These first authors contributed equally to this article.

Page created: March 06, 2025
Page updated: April 24, 2025
Page reviewed: April 24, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external